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ABSTRACT Cdc6p has an essential function in the mech-
anism and regulation of the initiation of DNA replication.
Budding yeast Cdc6p binds to chromatin near autonomously
replicating sequence elements in late M to early G1 phase
through an interaction with Origin Recognition Complex or
another origin-associated factor. It then facilitates the subse-
quent loading of the Mcm family of proteins near autonomously
replicating sequence elements by an unknown mechanism. All
Cdc6p homologues contain a bipartite Walker ATP-binding
motif that suggests that ATP binding or hydrolysis may regulate
Cdc6p activity. To determine whether these motifs are important
for Cdc6p activity, mutations were made in conserved residues of
the Walker A and B motifs. Substitution of lysine 114 to alanine
(K114A) in the Walker A motif results in a temperature-sensitive
phenotype in yeast and slower progression into S phase at the
permissive temperature. A K114E mutation is lethal. The
Cdc6K114E protein binds to chromatin but fails to promote
loading of the Mcm proteins, suggesting that ATP binding is
essential for this activity. The mutant arrests with a G1 DNA
content but retains the ability to restrain mitosis in the absence
of DNA replication, unlike depletion of Cdc6p. In contrast, Cdc6p
containing a double alanine mutation in the Walker B motif,
DE(223, 224)AA, is functional, and the mutant exhibits an
apparently normal S phase. These results suggest that Cdc6p
nucleotide binding is important for establishing the prereplica-
tive complex at origins of DNA replication and that the amino
terminus of Cdc6p is required for blocking entry into mitosis.
The initiation of DNA replication in eukaryotes occurs at mul-
tiple cis-acting sequences, termed replicators, ensuring that DNA
replication occurs only during the S phase of the cell division
cycle. Origin Recognition Complex (ORC) is a multisubunit
protein complex that binds to replicators (1), is required for
initiation (2–4) and so fulfills the classical definition of an initiator
protein. However, ORC itself does not appear to have an origin
unwinding activity (5), and it is known that many additional
proteins are required for initiation (6). Because the genome must
be precisely duplicated, each active replicator is normally allowed
to initiate replication only once per cell cycle, and numerous
studies have revealed that control of initiation mediates this
precision (2, 7, 8).
The initiation phase of DNA replication has been most studied
in the unicellular eukaryote Saccharomyces cerevisiae. Simple
DNA sequences, termed autonomously replicating sequence
(ARS) elements, have been shown to function as replicators and
to contain origins of replication, the actual physical sites where
DNA synthesis begins (9–12). These replicators exist in at least
three states during the cell cycle, reflecting the recruitment of
replication factors in an ordered fashion before the initiation of
bidirectional replication (13–21). In order of assembly, these are
the post-replicative complex (post-RC) that is detected after
initiation in S phase until M phase; the pre-replicative complex
(pre-RC) that exists from late mitosis to G1 phase; and the
pre-initiation complex that is present in late G1. The precise
protein composition at ARS elements during each of these states
remains unknown; however, ORC, Cdc6p, Cdc45p, and the Mcm
proteins are known components (16, 20).
ORC is bound to chromatin and to specific replicators at all
times during the cell cycle (16, 18, 20). In vivo genomic footprints
of ARS1 after initiation produce a pattern of DNase I cleavage
that is very similar to that obtained with ORC and naked ARS1
DNA, suggesting that ORC alone may be bound to origins in the
post-RC state (13). The pre-RC complex detected by genomic
footprinting requires at least the presence of ORC, Cdc6p, and
the Mcm proteins (14, 15, 17). Cdc6p is required to load the Mcm
proteins onto chromatin and this can occur only from late in
mitosis to late in G1 phase, when the M-phase and S-phase
cyclin-dependent kinases are inactive (15, 17, 18, 20, 22, 23).
Similar observations have been made in other species including
Xenopus and Schizosaccharomyces pombe (7, 24, 25). This assem-
bly is inhibited by active cyclin-dependent kinases that are in turn
inhibited by Sic1p (20, 26). After activation of the Clb-cyclin-
dependent kinases in late G1 by degradation of Sic1p, Cdc45p
binds to chromatin as part of a large complex called the preini-
tiation complex (21).
It is clear that Cdc6p levels in the cell control the frequency of
initiation throughout the genome (10) and gain-of-function mu-
tations in CDC6 can cause reinitiation in a single cell cycle (18).
To investigate whether the ATP-binding motifs present in Cdc6p
are important for either chromatin binding or Mcmp loading, we
have made mutations in conserved regions of the Walker A and
B motifs required for stable binding and hydrolysis of ATP (27).
This analysis reveals that Cdc6p binds to chromatin regardless of
mutations in the ATP-binding sites, at least one of which would
be predicted to severely impair ATP binding. Although
Cdc6K114Ep cannot load Mcm proteins or promote initiation, the
cells terminally arrest with a G1 content and do not undergo the
reductional mitosis that occurs with depletion of Cdc6p (28).
These observations strongly suggest that the presence of Cdc6p is
sufficient to inhibit mitosis in the absence of ongoing DNA
synthesis. However, Cdc6K114Ep containing a deletion of the
amino terminus is no longer able to inhibit this reductional
division. The K114A mutation confers a temperature-sensitive
phenotype, and this mutant exhibits a slower progression into S
phase. Interestingly, although the adjacent DE residues contained
in the Walker B motif are conserved in all Cdc6 homologues
reported so far, a DE(223, 224)AA mutation results in no obvious
growth phenotype in S. cerevisiae. In addition, the timing of
chromatin binding for Cdc6p and all six Mcm proteins was
observed in a complete cell cycle.
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Strains and Plasmids. Genetic manipulation and transforma-
tion of yeast was done by using standard techniques (29, 30). All
strains of S. cerevisiae are derivatives of W303 (31) and are listed
in Table 1. pMW71 contains the 2.4-kb MluI to NheI genomic
CDC6 sequence in pRS415. All mutations in CDC6 were intro-
duced by using site-directed mutagenesis of single-stranded ura-
cil-containing phagemid DNA. After DNA sequencing, restric-
tion fragments containing only the desired mutation were ex-
changed into pMW71. These are pMW95 (K114E), pMW125
(K114A), pMW126 (K114R), pMW302 (DN) that deletes amino
acids 2–48, pMW369 (DE(223, 224)AA), and pMW389 (DN,
K114E). After testing complementation by plasmid shuffling,
wild-type CDC6 and selected mutants were cloned into pRS405
and then integrated into the LEU2 locus of K4055 after linear-
ization with HpaI. Genomic Southern blots confirmed single-
copy integrations and the sequence of the integrated CDC6 was
determined after PCR to confirm the presence of the desired
mutation. K4055 and derivatives were always cultured in synthetic
complex (SC) medium (29) lacking methionine and also without
leucine for the CDC6 integrants. Methionine (2 mM) was added
to the medium or plates to repress the wild-type copy of CDC6
under control of the MET3 promoter, as in Fig. 2B. YB511 was
created to detect all six Mcm proteins with specific antibodies.
Details of construction are available on request.
Fluorescence-Activated Cell Sorter (FACS) Analysis. For the
methionine shutoff experiments in Fig. 3, all cultures were grown
at 30°C to logarithmic phase. Methionine was added to 2 mM and
cell aliquots were processed as described (18). To synchronize
cultures in G1 (Fig. 4), cells were grown to logarithmic phase in
YPD (1% yeast extract, 2% bactopeptone, 2% glucose) at 25°C
and a-factor was added to 10 mgyml. After 1 hr, additional
a-factor was added to 5 mgyml, and the cultures were incubated
1.5 hr further. Time points were taken after collecting the cells,
resuspending in an equivalent volume of YPD lacking a-factor,
and culturing at 25°C.
Chromatin-Binding Analysis. For analyzing Cdc6p and Mcm
protein chromatin binding through the cell cycle (Fig. 1), YB511
was grown to exponential phase in YPD at 25°C and shifted to
37°C for 3 hr. The culture was returned to 25°C and cell aliquots
were taken and processed as below. For the experiments with
conditional expression of CDC6, K4055, and YB502–505 were
grown at 30°C to logarithmic phase. Cultures were synchronized
in G2yM after two additions of nocodazole to 20 mgyml at 0 and
60 min. At 120 min, 2 mM methionine was added to the culture
(to repress the wild-type pMET3-CDC6) and incubated an addi-
tional 30 min. Cultures were then released into SC medium
without nocodazole but containing 10 mgyml a-factor with or
without 2 mM methionine. Time points were taken at 0, 30, 60,
and 90 min after nocodazole release. All samples were processed
into soluble and insoluble (chromatin) fractions after Nonidet
P-40 lysis of yeast spheroplasts as described (18). Equivalent
amounts of these fractions were loaded onto SDS-10% polyacryl-
amide gels, transferred to nitrocellulose, and probed by using
monoclonal antibodies against Mcm2p (Mcm2–18, 1:5,000),
Mcm3p (Mcm3–28, 1:5,000), Mcm4p-T7 [T7 (Novagen) 1:5,000],
Mcm5p (Mcm5–32, 1:5,000), Mcm6p-HA3 (12CA5, 1:5,000),
Mcm7p-Myc7 (9E10, 1:1,000), Orc3p (SB3, 1:50,000), Orc6p
(SB49, 1:1,000), and Cdc6p (9H8y5, 1:1,000) (17). The monoclo-
nal antibodies against the Mcm proteins will be described else-
where (M. Akiyama, M.W., and B.S., manuscript in preparation).
RESULTS
Timing of Cdc6p and Mcm Protein Chromatin Association.
ORC is bound to chromatin at ARS elements during all stages of
the cell division cycle (16, 18) and recruits other proteins that are
required for the initiation of DNA replication. Cdc6p associates
with chromatin late in mitosis and promotes the binding of the
Mcm proteins near ARS elements (17, 20); however, it is not
known whether all Mcm proteins become associated with chro-
matin at the same time relative to Cdc6p binding. We examined
the timing of Cdc6p chromatin binding at 5-min intervals after
release from a dbf2–1 block that arrests cells in late mitosis and
compared this to the chromatin association of all six Mcm
proteins. Soluble and chromatin-enriched fractions were isolated
(18), and proteins present in the chromatin fraction are shown in
Fig. 1B. Orc3p and Orc6p chromatin binding are shown because
ORC is chromatin bound throughout the cell cycle. Note that
Orc6p becomes phosphorylated at the G1-S transition and de-
phosphorylated at the passage through mitosis (18). Thus, along
with DNA content analysis (Fig. 1A), this is an excellent marker
for cell-cycle stage.
Cdc6p and all six Mcm proteins load onto chromatin as cells
exit mitosis, with Cdc6p loading first at 15 min after release from
the dbf2–1 block (Fig. 1B). All proteins remain on chromatin
throughout G1, but the majority of Cdc6p is unloaded as cells
prepare to enter S phase. Thus it is likely that Cdc6p is removed
from all origins before entry into S phase. In contrast, the Mcm
proteins are gradually released, perhaps reflecting their release
from both early and late origins and as cells replicate DNA (16).
Cdc6p and the Mcm proteins then rebind to chromatin for the
next chromosome replication cycle at 110 min when the cells still
have a G2yM DNA content.
Mutations in the CDC6 Walker A Box Impair Its Function. S.
cerevisiae Cdc6p contains a bipartite Walker ATP-binding motif
(27) that is conserved in numerous Cdc6p homologues (Fig. 2A).
To test their importance for Cdc6p activity, we made changes in
the conserved Walker A and B motifs and expressed the mutant
Table 1. Strains
Strain Genotype Source
W303-1A Mata leu2-3,112 trp1-1 ura3-1 his3-11,15 can1-100 ade2-1 R. Rothstein
K4055 W303 Mata cdc6D<hisG pMET3-CDC6<TRP1 K. Nasmyth
K6210 W303 Mata MCM7(Myc7)-URA3 0
YB209 W303 Mata cdc6D/pRS426-CDC6 (10)
YB495 W303 Mata cdc6D/pRS426-CDC6 This study
YB496 YB209/pMW71 0
YB497 YB209/pMW126 0
YB502 K4055 CDC6<LEU2 0
YB503 K4055 cdc6K114A<LEU2 0
YB504 K4055 cdc6K114E<LEU2 0
YB505 K4055 cdc6DE(223,224)AA<LEU2 0
YB506 K4055 cdc6DN,K114E<LEU2 0
YB507 YB209 CDC6<LEU2 0
YB508 YB209 cdc6K114A<LEU2 0
YB510 YB209 cdc6DE(223,224)AA<LEU2 0
YB511 W303 Mata dbf2-1 MCM4(T7)-HIS3 MCM6(HA3)-LEU2 MCM7(Myc7)-URA3 0
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genes from the endogenous CDC6 promoter. Lysine 114 of the
Walker A motif is expected to be critical for correct orientation
of the b-g phosphates of ATP (32). A conservative mutation to
arginine, cdc6K114R, had no effect on cell growth or in S-phase
progression as determined by plasmid complementation and flow
cytometry (data not shown). However, an alanine mutation,
cdc6K114A, resulted in a temperature-sensitive phenotype and a
mutation to glutamate, cdc6K114E, was lethal (Fig. 2B). The
glutamate substitution would create an ionic repulsion with the
phosphates of ATP in the binding pocket and probably hinder
ATP binding (33). Both the cdc6K114A and cdc6K114E mutants are
recessive to the wild type in diploid yeast (data not shown).
The adjacent aspartic and glutamic acid residues in the Walker
B motif are thought to be important for proper positioning of
ATP through coordination of a Mg21 ion and have been pro-
posed to play a role in ATP hydrolysis (34–36). Surprisingly, the
double mutation cdc6DE(223, 224)AA had little effect on cell growth
either at 30°C or 37°C (Fig. 2B), even though these residues are
absolutely conserved in the human, Xenopus, and S. pombe CDC6
homologues. This observation suggests that an intact Walker B
motif is not essential for Cdc6p activity.
Cdc6K114Ep Is Capable of Inhibiting Mitosis in the Absence of
Initiation. S. cerevisiae depleted of wild-type Cdc6p fail to initiate
DNA synthesis and eventually undergo an aberrant reductional
anaphase in which cells randomly segregate unreplicated chro-
mosomes, which is a lethal event (28). A similar phenotype was
observed when the S. pombe CDC6 homologue, cdc181 is deleted
(37), demonstrating a conserved role in coupling the initiation
and possibly completion of DNA synthesis to mitosis. To test
whether an intact ATP-binding motif was required for this
activity, cells containing either no additional CDC6 or CDC6
derivatives integrated at the LEU2 locus under control of the
CDC6 promoter were examined for DNA content after shutoff of
the methionine-dependent pMET3-CDC6 at an unlinked locus.
As previously demonstrated, cells depleted of Cdc6p initially
accumulate with a 1C DNA content because they are incapable
of initiating DNA synthesis. Beginning at 180 min after shutoff of
pMET3-CDC6, these cells undergo a premature mitosis and
accumulate with less than 1C DNA content (ref. 28; Fig. 3). The
cdc6K114E mutant also accumulates with a 1C DNA content
because it fails to enter S phase. However, these cells remain
arrested in G1 and fail to undergo this reductional division. This
FIG. 1. Chromatin binding analysis of Cdc6p and Mcm proteins in the cell cycle. (A) FACS profile of YB511 after a dbf2–1 arrest (37°C) and
release at 25°C. (B) Chromatin pellets of YB511 were probed for Orc3p, Orc6p, Cdc6p, and the six Mcm proteins by using monoclonal antibodies
specific for each protein.
FIG. 2. Growth characteristics of CDC6 ATP-binding site mutants.
(A) A schematic of Cdc6p showing the regions of homology to RFC
and the AAA1 superfamily of proteins (44, 45). Below is an alignment
(from top to bottom) of the human (50), Xenopus (7), S. pombe (51),
and S. cerevisiae (40) Cdc6p Walker A and B motifs (underlined). The
amino acid changes in Cdc6p are indicated by the arrows at lysine 114
and the aspartic and glutamic acids 223 and 224. (B) Strains YB502,
YB503, YB504, and YB505 were streaked onto SC plates lacking
methionine (2Met), expressing pMET3-CDC6WT, or containing 2 mM
methionine (1Met), allowing expression of only the indicated CDC6
allele, and photographed after 2 days at 30°C and 37°C.
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observation demonstrates that the Walker A motif of Cdc6p is
required for the initiation of DNA replication, but it is not
necessary to prevent G1 cells from undergoing reductional mi-
tosis. If the amino terminus of cdc6K114E is deleted, cells also
accumulate with a 1C DNA content but now undergo a reduc-
tional division beginning at 180 min (Cdc6DN, K114E, Fig. 3). Thus,
although the amino terminus is dispensable for the essential role
of Cdc6p in initiation (38), it is required to inhibit premature
entry into mitosis.
cdc6K114A Is Slow to Initiate S Phase. To test whether the
nonlethal mutations affected S-phase progression, strains con-
taining only the wild-type or mutant CDC6 alleles were arrested
in G1 by using a-factor, released from the arrest and then
monitored by flow cytometry. The wild-type CDC6 and
cdc6DE(223, 224)AA strains initiated S phase with very similar ki-
netics, approximately 40 min after the a-factor release (Fig. 4).
The cdc6K114A strain, however, initiated S phase much later,
between 60 and 75 min after release from the G1 block (Fig.
4). This observation could indicate an inefficient establishment
of pre-RCs throughout the genome, as occurs with the original
cdc6–1 allele at the permissive temperature (10) and is con-
sistent with a defect in the initiation function of Cdc6p. The
cdc6DE(223, 224)AA mutant does exhibit a phenotype if this exper-
iment is performed in SC media, since the cells enter S phase
more slowly relative to the wild type, although S-phase pro-
gression is not as slow as for the cdc6K114A mutant (data not
shown).
Cdc6K114Ep Binds to Chromatin but Fails to Load Mcm
Proteins. One essential function of Cdc6p in initiation is to
promote the binding of Mcm proteins to chromatin at or near
ARS elements. Studies using both chromatin binding (17, 18) and
chromatin coimmunoprecipitation of ARS sequences with anti-
Cdc6p or Mcm antibodies (16, 20) revealed that Cdc6p binds to
ARS sequences and that Cdc6p is absolutely required for the
subsequent association of the Mcm proteins. However, it is not
known whether the binding of Cdc6p to chromatin and its ability
to load the Mcm proteins are dependent on ATP binding or
hydrolysis.
To test these possibilities, we determined whether the CDC6
ATP-binding site mutants allow chromatin binding of either
Cdc6p itself or the Mcm proteins. Because the cdc6K114E allele
does not allow growth of yeast, strains were grown by using a
wild-type CDC6 gene under control of the MET3 promoter,
arrested in G2yM with nocodazole and then released to a G1
(a-factor) block expressing only the wild-type and mutant alleles
of CDC6 from the natural promoter. Cells were arrested in
a-factor to provide a uniform arrest point in the cell cycle. Thus
the experiment determines whether Cdc6p or Mcmp can be
loaded onto chromatin and also measures the stability of the
proteins in the a-factor arrested state. Soluble and chromatin-
enriched fractions were isolated and the chromatin binding of
Cdc6p, ORC, and Mcm proteins was examined as cells entered
G1 phase (18).
Wild-type and mutant Cdc6 proteins are not bound to chro-
matin in cells arrested at G2yM by nocodazole (Fig. 5, lanes 1, 6,
11, and 16) but do bind to chromatin within 30 min of release from
the nocodazole block to the a-factor block (lanes 8, 13, and 18).
Chromatin samples of cells released from the nocodazole block
expressing wild-type pMET3-CDC6 are shown as a control (lanes
2, 7, 12, and 17). After a prolonged a-factor arrest, the amounts
of soluble (not shown) and chromatin-bound Cdc6p diminished
(e.g., lanes 8–10), probably reflecting the rapid turnover of this
protein (28). Cdc6K114Ep was less stable in the a-factor arrested
cells than the wild type or Cdc6DE(223, 224)AAp (lanes 13–15 vs.
lanes 8–10; 18–20) in this experiment. Nevertheless, Cdc6K114Ep
did bind to chromatin (Fig. 5, lane 13). As a control, no chro-
matin-bound Cdc6p was detected when the MET3 promoter was
FIG. 3. cdc6K114E fails to initiate S phase but inhibits mitosis.
Asynchronous cultures of K4055, YB504, and YB506 were grown to
exponential phase in SC medium lacking methionine. Methionine was
added to 2 mM to repress the wild-type pMET3-CDC6 present in all
strains, and time points were processed for FACS analysis. From left
to right, strains encode no CDC6, or either cdc6K114E or cdc6DN, K114E
integrated at the LEU2 locus and under the control of the CDC6
promoter.
FIG. 4. The cdc6K114A mutant moves more slowly into S phase.
YB507, YB508, and YB510 were grown to exponential phase in YPD,
arrested in G1 with a-factor, released from the block and monitored
by FACS for entry into S phase.
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shut off and no additional copy of CDC6 was present (lanes 3–5),
indicating that the pMET3-CDC6 copy was completely repressed.
The chromatin binding of both Mcm2p and Mcm3p was also
determined. At the nocodazole block, the Mcm proteins were
not bound to chromatin but were present in the soluble
fraction (not shown), as previously reported (17, 18). On
release from the G2yM block, the Mcm proteins were loaded
onto chromatin in G1 when the wild-type Cdc6p (Fig. 5, lanes
8–10), Cdc6DE(223, 224)AAp (lanes 18–20), or Cdc6K114Ap (not
shown) proteins were expressed. In contrast, the Mcm proteins
were not loaded when no Cdc6p was expressed (lanes 3–5) or only
the Cdc6K114Ep mutant was expressed (lanes 13–15), suggesting
that ATP binding was required for Cdc6 to load the Mcm
proteins.
As a control, Orc3p and Orc6p were bound to chromatin at all
times during this experiment. Interestingly, Orc6p went from a
phosphorylated to a nonphosphorylated form of greater mobility
between the G2yM block and release into the G1 arrest (Fig. 5,
compare lanes 1 and 2). Dephosphorylation after release from
nocodazole probably reflects inactivation of the mitotic form of
the Cdc28p kinase and an unknown phosphatase. Dephosphor-
ylation of Orc6p served as a marker for progression into G1. At
30 min after release from nocodazole, only half of the cells have
a G1 DNA content (not shown), and Orc6p was still partially
phosphorylated (Fig. 5, lanes 3, 8, 13, and 18). By 60 min, all of
the cells had a G1 DNA content and Orc6p was completely
dephosphorylated (Fig. 5, lanes 4, 9, 14, and 19).
DISCUSSION
Cdc6p is required at a very early stage leading to the initiation of
DNA replication. It is synthesized in late M phase (28, 39), binds
to chromatin at ARS elements (20) and is required for the
subsequent loading of the Mcm proteins (17). We show that
Cdc6p is unloaded from chromatin before all of the Mcm
proteins, perhaps being unloaded simultaneously from origins
that fire both early and late in S phase. In contrast, the Mcm
proteins exit chromatin more slowly, maybe in a replicon-specific
manner (Fig. 1; 16, 20). In addition, Cdc6p somehow acts to
inhibit mitosis in S. cerevisiae. Overproduction of Cdc6p causes a
transient delay in mitosis (40), and depletion of Cdc6p results in
an initial G1 arrest, followed by a reductional mitosis resulting in
haploid cells with less than 1C DNA content (28).
All Cdc6p homologues contain a conserved bipartite ATP-
binding motif, strongly suggesting that ATP binding and perhaps
hydrolysis are important aspects of Cdc6p function. We have
shown that mutations in the Walker A motif inactivate Cdc6p. A
K114A mutation results in a ts phenotype, and a K114E mutation
is lethal. Both of these proteins bind to chromatin with apparently
normal kinetics after release from a mitotic block. Cdc6K114Ep,
however, is unable to load Mcm2p and Mcm3p, strongly suggest-
ing that Cdc6p requires ATP binding to promote loading of the
Mcm proteins.
An earlier report (41) has suggested that GST-Cdc6p ex-
pressed in Escherichia coli is an ATPase; however, all of our
attempts to detect a specific ATP-binding or ATPase activity for
Cdc6p have been unsuccessful (J. Mendez, M.W., and B.S.,
unpublished work). It is possible that ATP binding and hydrolysis
are regulated through interaction with other proteins or with
DNA. It is noteworthy that the related Orc1p has conserved
Walker A and B motifs and origin DNA modulates its ATPase
activity (5).
Cdc6K114Ep binds to chromatin, and so presumably its inter-
action near ARS elements is maintained. This mutant protein is
also able to inhibit mitosis in the absence of the initiation of DNA
replication, since we do not observe a reductional division in the
absence of S phase. Because the ability to inhibit mitosis does not
require the Mcm-loading activity of Cdc6p, by this criterion the
mitotic function is separable from this essential initiation func-
tion. These results demonstrate that it is not merely the absence
of initiation that triggers a reductional mitosis, but that some
active function of Cdc6p is required to inhibit mitosis. Deletion of
the amino terminus of Cdc6p abrogates this effect. Thus the
inhibition of mitosis may be caused by the ability of Cdc6p to bind
and inhibit Cdc28p kinase (42, 43) or to interact with the Cdc4p
ubiquitin-dependent proteolytic pathway (38), since both of these
interactions require the amino terminus of Cdc6p.
Two recent reports have shown a similarity of Cdc6p to a broad
family of ATPases (44, 45), including RFC, a structure-specific
DNA-binding protein that loads the ring-shaped proliferating cell
nuclear antigen molecule onto primed DNA (46). This family is
involved in diverse cellular functions, but all somehow couple
ATP binding to structural changes in themselves or other pro-
teins. The similarity extends over eight regions corresponding to
seven of the eight RFC homology boxes (47) and the sensor I
motif (33), a region of the protein predicted to be important for
coordinating ATP binding to structural changes or activities of
this class of proteins. Inclusion of Cdc6p in this family suggests
that Cdc6p may couple ATP binding or hydrolysis to remodeling
or loading proteins directly at replicators. This suggestion is in
excellent agreement with the known requirement of Cdc6p for
promoting assembly of the Mcm proteins at origins. Furthermore,
we recently reported a cdc6 mutant in which Mcm proteins
remained bound to chromatin after S phase, causing reinitiation
of DNA replication (18). One of the mutations in cdc6–3 maps
to the conserved sensor I motif, raising the possibility that this
mutation may alter the conformation of Cdc6p to mimic an
activated ATP-bound state.
Walker’s original designation of the B motif contained a stretch
of hydrophobic residues ending in an aspartic acid residue (27),
because a number of ATP-binding proteins, kinases, helicases,
and ATP synthases have been reported to contain signature
motifs that are variations of the ‘‘B motif’’ (34, 48, 49). Cdc6p
homologues conform to this designation in having five hydro-
phobic residues followed by DEMD (Fig. 2A). This is similar to
the B motif of the ‘‘DEADyH box’’ family of helicases (34). By
analogy to ATP-binding proteins of known structure (35, 36),
these acidic residues of Cdc6p should be important for coordi-
nating the Mg21 ion in the bound Mg21ATP and also for
hydrolysis of ATP. Surprisingly, mutation of both DE residues to
alanine in CDC6 has little effect on the viability of yeast or
progression into S phase. This observation suggests that if Cdc6p
is an ATPase, hydrolysis of ATP may not be required for its
FIG. 5. Cdc6 proteins bind to chromatin but Cdc6K114Ep fails to
promote loading of Mcm proteins. Western blots of chromatin frac-
tions from cells (K4055, YB502, YB504, YB505) blocked in G2yM
with nocodazole and released to an a-factor (G1) block for 309, 609,
or 909 expressing the indicated CDC6 alleles. Lanes 1, 6, 11, and 16 are
the chromatin fractions at the nocodazole arrest. Lanes 2, 7, 12, and
17 are the chromatin fractions released to a-factor for 609 in cells
expressing wild-type CDC6 from the MET3 promoter (i.e., no methi-
onine). The next three lanes of each set (e.g., 3–5) represent chromatin
fractions released to an a-factor block for 309, 609, and 909 expressing,
from left to right, no CDC6, CDC6WT, cdc6K114E, or cdc6DE(223, 224)AA.
Blots were probed for Cdc6p, Mcm2p, Mcm3p, and Orc3p plus Orc6p.
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activity. ATP hydrolysis might instead be linked to the inactiva-
tion of Cdc6p.
A recent report also examined mutations in the Cdc6p Walker
A and B motifs (44). It was found that an E224G mutation in the
Walker B motif of CDC6 is lethal when the protein is overpro-
duced, blocking cells in late G1 to early S phase and this protein
is unable to load Mcm5p onto chromatin. Although we agree that
the Walker A-box is essential for Cdc6p activity, we suggest that
the integrity of the B motif is not essential for Cdc6p function,
since we see little effect of the DE(223, 224)AA mutation or by
overproducing this mutant Cdc6p with or without the amino
terminus (not shown). In addition, cdc6E224G can complement a
CDC6 deletion strain by using a plasmid shuffle assay, albeit with
very slow growth (our unpublished results). Perhaps the E224G
mutation additionally alters the conformation of Cdc6p outside
of the B motif, resulting in a protein that interferes with initiation
when overproduced.
We suggest a model for Cdc6p activity based on the available
evidence. Cdc6p is synthesized in late M phase (28, 39), and then
likely associates with ORC bound to replicators (Fig. 1; refs. 10,
20). Soon after binding to chromatin, Cdc6p promotes loading of
the Mcm proteins in a step that requires ATP binding but not
ATP hydrolysis. This proposal is exactly analogous to RFC, which
requires ATP binding but not ATP hydrolysis to load prolifer-
ating cell nuclear antigen onto DNA (46). Hydrolysis of ATP may
instead lock Cdc6p to an inactive ADP-bound state that cannot
be recycled until a subsequent round of cell division or perhaps
de novo synthesis of Cdc6p. Because purified Cdc6p does not alter
the ORC footprint at ARS1 (M.W. and B.S., unpublished data)
and Cdc6p chromatin binding during late M and G1 phase does
not correlate precisely with the presence of the pre-RC footprint
(C.L. and B.S., unpublished data), we suggest that another
factor(s) is responsible for the loss of the hypersensitive site and
extended footprint seen in the post-RC to pre-RC transition.
Clearly, Cdc6p has other functions in the chromosome repli-
cation cycle. Cdc6p bound to replicators may be essential for
inhibiting mitosis until initiation of DNA replication has begun.
The unreplicated chromatin in G1 cells may resemble newly
synthesized chromatin in G2 cells, and the cell division machinery
may not be able to distinguish these two states. The presence of
Cdc6p on chromatin precisely during G1 (Fig. 1) may signal that
the chromatin is in a G1 state. When the initiation of DNA
replication is blocked because of the absence of Cdc6p but other
mitotic functions proceed normally, such as the activation of the
Cdc28yClb2p kinase, the unreplicated chromosomes become
attached to spindles and then undergo an abnormal reductional
division. When Cdc6p is present and able to bind to ATP, it
promotes the efficient loading of the Mcm proteins that stages the
origin for the subsequent steps leading to initiation, e.g., binding
of Cdc45p (21) and action of the Cdc7yDfb4p kinase (2–4).
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